Lineage Cell Therapeutics
LCTX
LCTX
62 hedge funds and large institutions have $66.3M invested in Lineage Cell Therapeutics in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.98% more ownership
Funds ownership: 32.33% → 37.31% (+5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
98% less call options, than puts
Call options by funds: $4K | Put options by funds: $199K
Holders
62
Holding in Top 10
1
Calls
$4K
Puts
$199K
Top Buyers
| 1 | +$11M | |
| 2 | +$606K | |
| 3 | +$447K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$312K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$145K |
Top Sellers
| 1 | -$196K | |
| 2 | -$176K | |
| 3 | -$170K | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
-$93K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$73K |